^
Association details:
| Biomarker: | NTRK1 fusion |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | KRC-108 (TrkA receptor inhibitor, c-MET inhibitor, FLT3 inhibitor, Aurora kinase A inhibitor, RON inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
Published date:
03/10/2022
Excerpt:
KRC-108...suppressed the growth of KM12C colon cancer cells harboring an NTRK1 gene fusion.
DOI:
10.4062/biomolther.2021.195
